Evidence map›Paper›PMID 26401513›Full record

ArticleAnnals of clinical and translational neurology2015

Genome-wide association study of neocortical Lewy-related pathology.

Terhi Peuralinna, Liisa Myllykangas, Minna Oinas, Mike A Nalls, Hannah A D Keage, Veli-Matti Isoviita, Miko Valori, Tuomo Polvikoski, Anders Paetau, Raimo Sulkava and 7 more

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. α-Synuclein Promotes Neuronal Dysfunction and Death by Disrupting the Binding of Ankyrin to β-Spectrin.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  8. Review
  9. Article
  10. Review
  11. Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases.Movement disorders : official journal of the Movement Disorder Society · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 4 countries.

Terhi PeuralinnaMolecular Neurology, Research Program Unit, Biomedicum, University of Helsinki Helsinki, Finland.
Liisa MyllykangasDepartment of Pathology, Haartman Institute, University of Helsinki and HUSLAB Helsinki, Finland ; Folkhalsan Institute of Genetics Helsinki, Finland.
Minna OinasDepartment of Pathology, Haartman Institute, University of Helsinki and HUSLAB Helsinki, Finland ; Department of Neurosurgery, Helsinki University Central Hospital Helsinki, Finland.
Mike A NallsMolecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, NIH Bethesda, Maryland.
Hannah A D KeageSchool of Psychology, Social Work and Social Policy, University of South Australia Adelaide, Australia ; Department of Public Health and Primary Care, University of Cambridge Cambridge, United Kingdom.
Veli-Matti IsoviitaMolecular Neurology, Research Program Unit, Biomedicum, University of Helsinki Helsinki, Finland.
Miko ValoriMolecular Neurology, Research Program Unit, Biomedicum, University of Helsinki Helsinki, Finland.
Tuomo PolvikoskiInstitute for Ageing and Health, Newcastle University Newcastle, United Kingdom.
Anders PaetauDepartment of Pathology, Haartman Institute, University of Helsinki and HUSLAB Helsinki, Finland.
Raimo SulkavaSchool of Public Health and Clinical Nutrition, University of Eastern Finland Kuopio, Finland.
Paul G InceDepartment of Neuroscience, University of Sheffield Sheffield, United Kingdom.
Julia ZaccaiDepartment of Public Health and Primary Care, University of Cambridge Cambridge, United Kingdom.
Carol BrayneDepartment of Public Health and Primary Care, University of Cambridge Cambridge, United Kingdom.
Bryan J TraynorNeuromuscular Diseases Research Group, Laboratory of Neurogenetics, National Institute on Aging, NIH Bethesda, Maryland.
John HardyReta Lila Weston Research Laboratories, Departments of Molecular Neuroscience and of Clinical Neuroscience, UCL Institute of Neurology Queen Square, London, United Kingdom.
Andrew B SingletonMolecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, NIH Bethesda, Maryland.
Pentti J TienariMolecular Neurology, Research Program Unit, Biomedicum, University of Helsinki Helsinki, Finland ; Department of Neurology, Helsinki University Central Hospital Helsinki, Finland.
University of Helsinki · FINational Institute on Aging · USUniversity of Cambridge · GBFolkhälsans Forskningscentrum · FIHelsinki University Hospital · FINewcastle Hospitals - Campus for Ageing and Vitality · GBUniversity College London · GBUniversity of Eastern Finland · FIUniversity of Sheffield · GBUniversity of South Australia · AU

Funding

Characterization of Normal Genomic VariabilityZIAAG000932 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW · 2009 to 2024
$11.3M
Genetic Analysis Of Non- Alzheimer's disease DementiasZIAAG000951 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW · 2009 to 2020
$5.6M
Genetic Analysis Of Alzheimer's DiseaseZ01AG000950 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW · 2002 to 2008
$1.0M
Intramural NIH HHS Z01 AG000950Intramural NIH HHS ZIA AG000932Medical Research Council G0400074Medical Research Council G0502157Medical Research Council G0900582Medical Research Council G0900652Medical Research Council G1100540Medical Research Council G9901400Medical Research Council MR/L016451/1Medical Research Council MR/L022656/1
6 · The paper itself

Abstract

objectiveDementia with Lewy bodies is an α-synucleinopathy characterized by neocortical Lewy-related pathology (LRP). We carried out a genome-wide association study (GWAS) on neocortical LRP in a population-based sample of subjects aged 85 or over.

methodsLRP was analyzed in 304 subjects in the Vantaa 85+ sample from Southern Finland. The GWAS included 41 cases with midbrain, hippocampal, and neocortical LRP and 177 controls without midbrain and hippocampal LRP. The Medical Research Council Cognitive Function and Ageing Study (CFAS) material was used for replication (51 cases and 131 controls).

resultsBy analyzing 327,010 markers the top signal was obtained at the HLA-DPA1/DPB1 locus (P = 1.29 × 10(-7)); five other loci on chromosomes 15q14, 2p21, 2q31, 18p11, and 5q23 were associated with neocortical LRP at P < 10(-5). Two loci were marked by multiple markers, 2p21 (P = 3.9 × 10(-6), upstream of the SPTBN1 gene), and HLA-DPA1/DPB1; these were tested in the CFAS material. Single marker (P = 0.0035) and haplotype (P = 0.04) associations on 2p21 were replicated in CFAS, whereas HLA-DPA1/DPB1 association was not. Bioinformatic analyses suggest functional effects for the HLA-DPA1/DPB1 markers as well as the 15q14 marker rs8037309.

interpretationWe identified suggestive novel risk factors for neocortical LRP. SPTBN1 is the candidate on 2p21, it encodes beta-spectrin, an α-synuclein binding protein and a component of Lewy bodies. The HLA-DPA1/DPB1 association suggests a role for antigen presentation or alternatively, cis-regulatory effects, one of the regulated neighboring genes identified here (vacuolar protein sorting 52) plays a role in vesicular trafficking and has been shown to interact with α-synuclein in a yeast model.

Identifiers

PMID26401513
PMCPMC4574809
OpenAlexW2128969686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.